Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history shows the addition of Revision: v3.3.2 and removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page history now shows Revision: v3.3.1 in place of Revision: v3.2.0 as part of a system update.SummaryDifference0.0%

- Check29 days agoChange DetectedThe lapse-in-funding notice about potential data delays and operating status has been removed from the page.SummaryDifference0.3%

- Check43 days agoChange DetectedThe images reflect added version entries in the Record History, with updated dates and statuses, while the main study data remains unchanged.SummaryDifference0.1%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference8%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.